Integrated Biosciences
Biotechnology company combining synthetic biology and machine learning to control cellular stress responses for next-generation therapeutics targeting aging and age-related diseases.
Notes
Integrated Biosciences is a biotechnology company that combines synthetic biology and machine learning to understand and manipulate cellular stress responses. The company's approach aims to develop therapeutics that can extend healthy lifespan by targeting fundamental mechanisms of cellular aging and stress.
The company's platform integrates high-throughput synthetic biology experiments with AI/ML analysis to discover compounds and pathways that modulate how cells respond to various stressors. This approach has applications in developing treatments for age-related diseases and potentially interventions that affect the aging process itself.
Integrated Biosciences represents a new wave of longevity-focused biotechs that apply cutting-edge computational and experimental technologies to aging research.
Team
- Felix Wong, Ph.D. - CEO & Co-founder
- Background in systems biology and AI
- Team with expertise in synthetic biology, machine learning, and drug discovery
Additional Research Findings
- Founded in 2020, based in San Carlos, California
- Combines synthetic biology + AI/ML
- Focus on cellular stress responses
- Longevity and age-related disease applications
- High-throughput experimentation platform
- Drug discovery for aging interventions
- Backed by longevity-focused investors
- Part of growing longevity biotech sector
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |